看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 26.1x - 28.8x | 27.5x |
| Selected Fwd Ps Multiple | 16.3x - 18.0x | 17.1x |
| Fair Value | ¥10.02 - ¥11.08 | ¥10.55 |
| Upside | -20.8% - -12.4% | -16.6% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Globus Medical, Inc. | - | NYSE:GMED |
| Shanghai HeartCare Medical Technology Corporation Limited | 660,900.0% | SEHK:6609 |
| LifeTech Scientific Corporation | 130,200.0% | SEHK:1302 |
| Angelalign Technology Inc. | 669,900.0% | SEHK:6699 |
| Acotec Scientific Holdings Limited | 666,900.0% | SEHK:6669 |
| Tinavi Medical Technologies Co.,Ltd. | 68,827,700.0% | SHSE:688277 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| GMED | 6609 | 1302 | 6699 | 6669 | 688277 | |||
| NYSE:GMED | SEHK:6609 | SEHK:1302 | SEHK:6699 | SEHK:6669 | SHSE:688277 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 26.3% | NM- | 17.9% | 23.7% | 33.7% | 10.6% | ||
| 3Y CAGR | 38.0% | 45.6% | 25.4% | 10.3% | 20.7% | 15.6% | ||
| Latest Twelve Months | 60.6% | 19.6% | 8.4% | -81.8% | 12.7% | -18.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 13.1% | -266.3% | 24.4% | 13.8% | -3.9% | -51.0% | ||
| Prior Fiscal Year | 7.8% | -40.5% | 29.6% | 3.6% | 3.1% | -70.8% | ||
| Latest Fiscal Year | 4.1% | -4.9% | 20.8% | 4.5% | 9.8% | -74.5% | ||
| Latest Twelve Months | 4.1% | -4.9% | 19.4% | 4.5% | 9.8% | -95.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 13.8x | 47.1x | 16.8x | 72.7x | 36.6x | -31.0x | ||
| Price / LTM Sales | 4.0x | 4.0x | 5.5x | 4.6x | 4.2x | 33.7x | ||
| LTM P/E Ratio | 96.9x | -82.2x | 28.2x | 102.7x | 43.1x | -35.4x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 4.0x | 4.2x | 5.5x | |||||
| Historical LTM P/S Ratio | 28.8x | 52.0x | 69.8x | |||||
| Selected Price / Sales Multiple | 26.1x | 27.5x | 28.8x | |||||
| (x) LTM Sales | 168 | 168 | 168 | |||||
| (=) Equity Value | 4,395 | 4,627 | 4,858 | |||||
| (/) Shares Outstanding | 449.4 | 449.4 | 449.4 | |||||
| Implied Value Range | 9.78 | 10.30 | 10.81 | |||||
| FX Rate: CNY/CNY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 9.78 | 10.30 | 10.81 | 12.65 | ||||
| Upside / (Downside) | -22.7% | -18.6% | -14.5% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | GMED | 6609 | 1302 | 6699 | 6669 | 688277 | |
| Value of Common Equity | 9,979 | 1,120 | 7,004 | 1,244 | 2,253 | 5,685 | |
| (/) Shares Outstanding | 137.5 | 38.1 | 4,630.6 | 170.0 | 313.4 | 449.4 | |
| Implied Stock Price | 72.55 | 29.37 | 1.51 | 7.31 | 7.19 | 12.65 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.93 | 0.93 | 0.13 | 0.93 | 1.00 | |
| Implied Stock Price (Trading Cur) | 72.55 | 31.45 | 1.62 | 56.90 | 7.70 | 12.65 | |
| Trading Currency | USD | HKD | HKD | HKD | HKD | CNY | |
| FX Rate to Reporting Currency | 1.00 | 0.93 | 0.93 | 0.13 | 0.93 | 1.00 | |